Dr. Pradeep completed her Ph.D. from India where she focused on developing novel immunomodulatory and anti-angiogenic agents in cancer models. She then joined Weizmann Institute of Science in Israel for her postdoctoral research where she continued research on discovering novel anti-angiogenic compounds.